{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fungal-skin-infection-body-groin/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"aa17d36a-2510-5bdd-b47b-2b2182e55fb9","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field e16f343d-db08-4904-ae8c-675709db541d --><h2>How should I assess suspected fungal infection of the body and groin?</h2><!-- end field e16f343d-db08-4904-ae8c-675709db541d -->","summary":"","htmlStringContent":"<!-- begin item ce327f7a-3552-49de-ae4a-c35fe52ff6fb --><!-- begin field c1058049-a5f2-4742-8240-a072f980a292 --><p><strong>If fungal infection of the body and groin is <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/diagnosis/diagnosis/\">suspected</a> on the basis of clinical features:</strong></p><ul><li>Ask the person about:<ul><li>The nature, site, and duration of any symptoms, such as an itchy, flaky skin on the body and or groin(s).</li><li>Any previous treatments, including over-the-counter preparations.</li><li>Any family or close contacts affected.</li><li>Any co-morbidities such as underlying causes of immunosuppression.</li></ul></li><li>Examine the person to assess:<ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/diagnosis/diagnosis/\">pattern</a>, extent, and severity of infection, and for any associated inflammation.</li><li>For complications such as <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/background-information/complications/\">tinea incognito</a> resulting from inappropriate use of topical corticosteroids. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information on other signs of topical corticosteroid overuse.</li><li>For any associated fungal infection at other sites, such as the nails, feet, or hands, which may need treatment. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-nail-infection/\">Fungal nail infection</a> and <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-foot/\">Fungal skin infection - foot</a> for more information.</li></ul></li><li>Be aware that diagnostic tests are not usually needed in primary care, but arrange for <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/diagnosis/assessment/#taking-skin-samples\">skin sampling</a> for fungal microscopy and culture, to confirm the diagnosis and identify the underlying cause, if:<ul><li>There is severe or extensive disease in adults.</li><li>The diagnosis is uncertain or there is an atypical appearance.</li></ul></li><li>Be aware that Wood's light examination is not needed to aid diagnosis in primary care.</li></ul><!-- end field c1058049-a5f2-4742-8240-a072f980a292 --><!-- end item ce327f7a-3552-49de-ae4a-c35fe52ff6fb -->","topic":{"id":"10689662-2594-5bc5-aacc-6f0297698637","topicId":"0a9103d8-0e5e-4e22-8ed1-df6caa2888c6","topicName":"Fungal skin infection - body and groin ","slug":"fungal-skin-infection-body-groin","lastRevised":"Last revised in May 2018","chapters":[{"id":"f9a7dce7-311f-5a13-b2c1-c8cd43e2838e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"38743423-24de-522e-95bd-4e728ae9bff6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1f4590f4-eb5c-5ac7-ae22-883e2e53a6ad","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"9df03477-c55a-5aee-a960-67b35e299585","slug":"changes","fullItemName":"Changes"},{"id":"ef4d507c-dbca-5b25-8c50-9054ba69b8a6","slug":"update","fullItemName":"Update"}]},{"id":"6a5be767-a22b-5a75-9497-6b23cdd8af40","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3333af1c-9f09-5390-98b9-e6486fea24ad","slug":"goals","fullItemName":"Goals"},{"id":"181bd2da-6331-5aa0-a497-5c0924b85b3d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"997df680-1de7-5ca8-bd57-bfdc04fc5708","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4c32deb8-71c7-5ff4-8ea7-21d5afcf46f0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"291e3f39-4ba8-5287-b429-ab9096f614d1","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7b7795b7-aa4b-5d16-9865-1f78a9aa7100","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"aa83eccd-4445-5d6a-85eb-2ec1398484cd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2993ff5f-d929-5124-b985-8bfe992b6123","slug":"definition","fullItemName":"Definition"},{"id":"e4bd4185-0aa9-5252-9ab8-9db4872de8e3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"3b35bce6-3614-5272-b2bc-7dfec9933540","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c9f8364f-4629-5bf0-9e81-6b5bc8fa4dc9","slug":"complications","fullItemName":"Complications"},{"id":"db007724-80ee-5dd6-bb25-70aa7c0fa306","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ddd3b119-1a06-5a24-a5c0-5bd1bdf86d33","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a8efce2f-87d2-504f-a1d5-92cbd6d2e262","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"aa17d36a-2510-5bdd-b47b-2b2182e55fb9","slug":"assessment","fullItemName":"Assessment"},{"id":"625c3efb-8f3e-5c3f-9743-9fb04531f418","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"ad2cfebe-3930-561d-8516-fccbfb956fbb","fullItemName":"Management","slug":"management","subChapters":[{"id":"058eae7f-c108-5ee2-9421-bce49270bd1d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"33c2524f-5b03-5298-b8b3-38f522d33ee3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"3f5f1a54-036e-5ade-823a-9bc062fe3b65","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"eb246451-6fc8-5e1c-af81-c0780be4ee3f","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"118430c7-7a53-56e6-a43c-ee7b3140563a","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"},{"id":"0a620672-cf78-5a49-83c9-b25a3860e2b9","slug":"oral-griseofulvin","fullItemName":"Oral griseofulvin"}]},{"id":"6118e788-fa21-5752-864e-3f16ec7b305d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bd6404d9-1abd-5cf0-99ee-b22f9fd18a84","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b7837228-7495-51a3-8ea2-973b7ec42868","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9bbac54b-39fb-522f-bfc7-ce8158baf074","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3c0e56a8-bb2e-5a9e-acbf-0fd43dda553c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f92ac5d0-593d-5b61-887b-d0be3a924870","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ececdb26-b868-5c5c-834a-dd5d3bdef118","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ab97556e-8246-5384-b5eb-167898e7b53d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ddd3b119-1a06-5a24-a5c0-5bd1bdf86d33","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e9fff784-25d9-5657-bf0b-b486973ed59d","slug":"taking-skin-samples","fullItemName":"Taking skin samples","depth":3,"htmlHeader":"<!-- begin field 948a4809-02fa-4ce6-8fc0-a8d300a898a8 --><h3>Taking skin samples</h3><!-- end field 948a4809-02fa-4ce6-8fc0-a8d300a898a8 -->","summary":null,"htmlStringContent":"<!-- begin item 579a65fb-6933-49ee-b67e-a8d300a8982f --><!-- begin field b03c4e78-8f59-4446-a121-a8d300a898a8 --><ul><li><strong>When taking skin samples for fungal microscopy and culture:</strong><ul><li>Wipe off any creams from the skin before sampling.</li><li>Scrape skin from the advancing edge of the lesion(s) with a blunt scalpel blade to collect skin scale. Sampling the edge of lesions may provide a higher yield of dermatophyte.</li><li>Collect at least 5 mm<sup>2 </sup>of skin flakes into folded dark paper squares secured with a paper clip. Alternatively, commercially available packs are available. Label the sample clearly.</li><li>Keep the samples at room temperature and do <em>not </em>refrigerate (dermatophytes are inhibited at low temperatures, and humidity facilitates the growth of contaminants).</li><li>Ensure clinical details provided on the microbiology request form include any treatment used, animal contacts, and overseas travel.</li><li>Inform the person microscopy results (to identify hyphae or spores) should be available within 1–2 days; culture results (to identify the causative organism) within 2–3 weeks.</li><li>Be aware that testing for antifungal susceptibilities is not required.</li></ul></li><li><strong>Consider arranging a skin swab for bacterial and fungal microscopy and culture if the skin is very pustular or macerated.</strong></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Moriarty et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>] </p><!-- end field b03c4e78-8f59-4446-a121-a8d300a898a8 --><!-- end item 579a65fb-6933-49ee-b67e-a8d300a8982f -->","subChapters":[]},{"id":"91979ef7-e8d6-5bed-9804-64b1eaa9c365","slug":"basis-for-recommendation-409","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 2a86313b-1e54-4688-b9d9-aeb47a8101e6 --><h3>Basis for recommendation</h3><!-- end field 2a86313b-1e54-4688-b9d9-aeb47a8101e6 -->","summary":null,"htmlStringContent":"<!-- begin item 40958de3-5f07-4401-b873-e1338dc3baaf --><!-- begin field d53a191c-300b-41f6-b5e3-45e91634e3d1 --><p>The recommendations on assessment of fungal infections of the body and groin are based on expert opinion in the Public Health England (PHE) publication <em>Fungal skin and nail infections: Diagnosis and laboratory investigation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>], and expert opinion in review articles on fungal skin infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Moriarty et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ely, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Gupta, 2017</a>], on corticosteroid-modified fungal skin infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Verma, 2017</a>], and on fungal foot infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ilkit, 2014</a>].</p><h4>Assessing the person</h4><ul><li>The recommendation to ask about any underlying causes of immunocompromise is based on the fact that this can lead to atypical presentations, extensive and severe fungal skin infections, that can be challenging to diagnose and treat in primary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Verma, 2017</a>].</li><li>The recommendation to assess for signs of tinea incognito and other signs of topical corticosteroid overuse is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Verma, 2017</a>].</li><li>The recommendation to assess other body sites is based on the fact that fungal foot infection can be an important reservoir for infection elsewhere, and can be transmitted often by autoinoculation, to the hands, groin, or nails [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ilkit, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Verma, 2017</a>].</li></ul><h4>Arranging skin sampling</h4><ul><li>The recommendation that skin sampling is not needed if there are clinical features of mild, uncomplicated fungal foot infection is based on expert opinion in the PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>] and in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ely, 2014</a>].</li><li>The recommendation to arrange skin sampling if there is an atypical appearance and the diagnosis is uncertain is based on expert opinion in the PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>] and in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ely, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Gupta, 2017</a>].</li><li>The recommendation to arrange skin sampling if there is severe or extensive disease in adults is based on the fact that this population group may need oral antifungal treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Moriarty et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Ely, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>].</li><li>The recommendation that antifungal susceptibility testing is not needed is based on the fact that antifungal resistance is rare, and there is no known correlation between antifungal susceptibilities and outcome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">PHE, 2017</a>].</li></ul><h4>Wood's light examination not needed</h4><ul><li>Wood's light examination is not recommended in primary care as the dermatophyte organisms which typically cause fungal infection of the body and groin in the UK, such as <em>Trichophyton rubrum</em>, do not fluoresce under Wood's light [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-body-groin/references/\">Moriarty et al, 2012</a>].</li></ul><!-- end field d53a191c-300b-41f6-b5e3-45e91634e3d1 --><!-- end item 40958de3-5f07-4401-b873-e1338dc3baaf -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}